Is the Treatment of Hepatocellular Carcinoma on the Waiting List Necessary?

被引：45
作者：
Majno, Pietro [1 ]
Lencioni, Riccardo [2 ]
Mornex, Francoise [3 ]
Girard, Nicolas [3 ]
Poon, Ronnie T. [4 ]
Cherqui, Daniel [5 ]
机构：
[1] Univ Hosp Geneva, Dept Transplantat & Visceral Surg, CH-1211 Geneva 14, Switzerland
[2] Pisa Univ Hosp, Div Diagnost Imaging & Intervent, Dept Hepatol & Liver Transplantat, Pisa, Italy
[3] Lyon Sud Hosp, Dept Radiat Oncol, Pierre Benite, France
[4] Univ Hong Kong, Dept Surg, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[5] New York Presbyterian Weill Cornell Med Ctr, Hepatobiliary Surg & Liver Transplantat Sect, Dept Surg, New York, NY USA
来源：
LIVER TRANSPLANTATION | 2011年 / 17卷
关键词：
INTENTION-TO-TREAT; DONOR LIVER-TRANSPLANTATION; TRANSARTERIAL CHEMOEMBOLIZATION; CIRRHOTIC-PATIENTS; DROP-OUT; RADIOFREQUENCY ABLATION; RECURRENCE; RESECTION; SURVIVAL; THERAPY;
D O I：
10.1002/lt.22391
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S98 / S108
页数：11
相关论文
共 49 条
[1]   A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation [J].
Aloia, Thomas A. ;
Adam, Rene ;
Samuel, Didier ;
Azoulay, Daniel ;
Castaing, Denis .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (10) :1328-1332
[2]   Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma [J].
Chao, S. D. ;
Roberts, J. P. ;
Farr, M. ;
Yao, F. Y. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1594-1600
[3]  
Cheow PC, 2005, HEPATOLOGY, V42, p333A
[4]   Liver Resection for Transplantable Hepatocellular Carcinoma Long-Term Survival and Role of Secondary Liver Transplantation [J].
Cherqui, Daniel ;
Laurent, Alexis ;
Mocellin, Nicolas ;
Tayar, Claude ;
Luciani, Alain ;
Jeanne Tran Van Nhieu ;
Decaens, Thomas ;
Hurtova, Monika ;
Memeo, Riccardo ;
Mallat, Ariane ;
Duvoux, Christophe .
ANNALS OF SURGERY, 2009, 250 (05) :738-746
[5]   Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis [J].
Choi, Byung Ock ;
Choi, Ihl Bohng ;
Jang, Hong Seok ;
Kang, Young Nam ;
Jang, Ji Sun ;
Bae, Si Hyun ;
Yoon, Seung Kew ;
Chai, Gyu Young ;
Kang, Ki Mun .
BMC CANCER, 2008, 8 (1)
[6]   Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates [J].
De Simone, P. ;
Vignali, C. ;
Petruccelli, S. ;
Carrai, P. ;
Coletti, L. ;
Montin, U. ;
Catalano, G. ;
Urbani, L. ;
Filipponi, F. .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) :3561-3563
[7]   Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma [J].
Decaens, T ;
Roudot-Thoraval, F ;
Bresson-Hadni, S ;
Meyer, C ;
Gugenheim, J ;
Durand, F ;
Bernard, PH ;
Boillot, O ;
Boudjema, K ;
Calmus, Y ;
Hardwigsen, J ;
Ducerf, C ;
Pageaux, GP ;
Dharancy, S ;
Chazouilleres, O ;
Dhumeaux, D ;
Cherqui, D ;
Duvoux, C .
LIVER TRANSPLANTATION, 2005, 11 (07) :767-775
[8]   Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation [J].
Fisher, R. A. ;
Kulik, L. M. ;
Freise, C. E. ;
Lok, A. S. F. ;
Shearon, T. H. ;
Brown, R. S., Jr. ;
Ghobrial, R. M. ;
Fair, J. H. ;
Olthoff, K. M. ;
Kam, I. ;
Berg, C. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1601-1608
[9]   Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list [J].
Fisher, RA ;
Maluf, D ;
Cotterell, AH ;
Stravitz, T ;
Wolfe, L ;
Luketic, V ;
Sterling, R ;
Shiffman, M ;
Posner, M .
CLINICAL TRANSPLANTATION, 2004, 18 (05) :502-512
[10]   Liver and intestine transplantation in the United States, 1997-2006 [J].
Freeman, R. B., Jr. ;
Steffick, D. E. ;
Guidinger, M. K. ;
Farmer, D. G. ;
Berg, C. L. ;
Merion, R. M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (04) :958-976
12345